on 3 Feb 2025
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2262663 filed on 29th Apr 2023
Registration Number
TMA1288165 registered on 3rd Feb 2025
Registration expiry Date
29th Apr 2033Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les m Read More12
2262663
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 13th Nov 2024 | Advertised |
Submitted for opposition 26 on 16th Oct 2024 | Approved |
Submitted for opposition 27 on 16th Oct 2024 | Approval Notice Sent |
Submitted for opposition 22 on 29th Aug 2024 | Search Recorded |
Submitted for opposition 256 on 8th Apr 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 8th Jun 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 7th Jun 2023 | Created |
Submitted for opposition 31 on 7th Jun 2023 | Formalized |
Submitted for opposition 30 on 29th Apr 2023 | Filed |
Submitted for opposition 228 on 29th Apr 2023 | International Registration |